News Cradle Genomics raises $17m for prenatal genetic testing R&D Prenatal testing firm Cradle Genomics has raised $17 million in an early funding round led by the investment arm of the genetic testing firm Illumina.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.